bromocriptine has been researched along with fluphenazine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (62.50) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH | 1 |
| Butler, DE; Coughenour, LL; DeWald, HA; Downs, DA; Heffner, TG; Lustgarten, D; Pugsley, TA; Wise, LD | 1 |
| Andaluz, B; Buschmann, H; Codony, X; Cubí, R; Díaz, JL; Dordal, A; Guitart, X; Hernández, E; Hernández, S; Holenz, J; Mas, J; Mercè, R; Monroy, X; Pérez, R; Romero, G; Sánchez, E; Sanfeliu, O; Torrens, A | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Barkey, RJ; Barzilai, D; Shani, J | 1 |
| Saiani, L; Spano, PF; Tonon, GC; Trabucchi, M | 1 |
| De Camilli, P; Macconi, D; Spada, A | 1 |
| Kellams, JJ; Lemberger, L; Rowe, H; Small, JG | 1 |
| Friedman, JH | 1 |
| Dambrosia, JM; Kebabian, JW; Miyazaki, K | 1 |
| Rampertaap, MP | 1 |
| Jenkins, JS; Prysor-Jones, RA; Silverlight, JJ | 1 |
| Bonomo, V; Parisi, R; Rapisarda, V | 1 |
| Blumhardt, C; Harris, P; Kellner, C | 1 |
| Király, I; Van Ree, JM | 1 |
| Albano, C; Roccatagliata, G | 1 |
| Adler, S; Coyle, J; Granato, JE; Karim, AH; Krumholz, A; Ringel, A; Stern, BJ | 1 |
| Pope, HG; Zubenko, G | 1 |
| Coulter, DM | 1 |
| Bunker, MT; Marken, PA; Ruehter, VL; Schneiderhan, ME | 1 |
2 review(s) available for bromocriptine and fluphenazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differential; Female; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia, Paranoid; Time Factors | 1986 |
22 other study(ies) available for bromocriptine and fluphenazine
| Article | Year |
|---|---|
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection | 1991 |
(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Ataxia; Avoidance Learning; Brain; Cebus; Chemical Phenomena; Chemistry; Dopamine; Male; Mice; Motor Activity; Movement Disorders; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Saimiri | 1986 |
Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
Topics: Adenylyl Cyclases; Benzoxazines; Cell Line; Humans; Indoles; Ligands; Piperidines; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Sulfonamides | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Regulation of prolactin binding sites in the seminal vesicle, prostate gland, testis and liver of intact and castrated adult rats: effect of administration of testosterone, 2-bromo-alpha-ergocryptine and fluphenazine.
Topics: Animals; Bromocriptine; Castration; Fluphenazine; Liver; Male; Prolactin; Prostate; Rats; Receptors, Cell Surface; Seminal Vesicles; Testis; Testosterone | 1979 |
Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum.
Topics: Animals; Bromocriptine; Corpus Striatum; Cyclic AMP; Dopamine Antagonists; Ergolines; Fluphenazine; In Vitro Techniques; Lisuride; Male; Rats | 1979 |
Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.
Topics: Adenoma; Adenylyl Cyclase Inhibitors; Bromocriptine; Dopamine; Fluphenazine; Humans; Norepinephrine; Pituitary Neoplasms; Prolactin; Receptors, Dopamine | 1979 |
The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
Topics: Acetonitriles; Amphetamine; Animals; Behavior; Bromocriptine; Dopamine Antagonists; Drug Interactions; Ergolines; Fluphenazine; Humans; Levodopa; Male; Rats; Stereotyped Behavior | 1977 |
"Rubral" tremor induced by a neuroleptic drug.
Topics: Adult; Benztropine; Bromocriptine; Corpus Striatum; Fluphenazine; Humans; Male; Neural Pathways; Red Nucleus; Substantia Nigra; Tremor | 1992 |
Dopaminergic modulation of the diethylstilbestrol-induced proliferation of the anterior pituitary gland of the Fisher 344 rat.
Topics: Animals; Bromocriptine; Cell Division; Diethylstilbestrol; Drug Interactions; Fluphenazine; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred F344; Receptors, Dopamine; Receptors, Dopamine D2 | 1985 |
Hyperprolactinemia reduces vasoactive intestinal peptide in the anterior pituitary glands of rats.
Topics: Animals; Bromocriptine; Drug Implants; Estradiol; Female; Fluphenazine; Hyperprolactinemia; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Vasoactive Intestinal Peptide | 1987 |
Long-acting therapy of schizophrenia.
Topics: Adolescent; Adult; Antiparkinson Agents; Benzodiazepines; Biofeedback, Psychology; Bromocriptine; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Pimozide; Schizophrenia; Trimeprazine | 1985 |
Concurrent use of bromocriptine and fluphenazine.
Topics: Adenoma, Chromophobe; Bromocriptine; Drug Interactions; Drug Therapy, Combination; Fluphenazine; Humans; Male; Middle Aged; Pituitary Neoplasms; Psychotic Disorders | 1985 |
Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; beta-Endorphin; Bromocriptine; Dopamine; Endorphins; Ergolines; Fluphenazine; gamma-Endorphin; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei; Sulpiride | 1984 |
[Therapy of Huntington's chorea: a pharmacological and clinical approach to the organization of the basal ganglia].
Topics: Adult; Aged; Baclofen; Basal Ganglia; Behavior; Biperiden; Bromocriptine; Female; Fluphenazine; Homovanillic Acid; Humans; Huntington Disease; Male; Middle Aged; Receptors, Dopamine | 1980 |
Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Drug Therapy, Combination; Fluphenazine; Humans; Male; Schizophrenia | 1983 |
Management of a case of neuroleptic malignant syndrome with bromocriptine.
Topics: Adult; Antiparkinson Agents; Autonomic Nervous System Diseases; Bromocriptine; Fever; Fluphenazine; Humans; Male; Muscle Rigidity | 1983 |
Prolactin: a hormonal regulator of the neonatal tissue water reservoir.
Topics: Animals; Animals, Newborn; Body Water; Body Weight; Bromocriptine; Fluphenazine; Prolactin; Rabbits; Water-Electrolyte Balance | 1983 |
Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
Topics: Adolescent; Amenorrhea; Antipsychotic Agents; Bromocriptine; Clozapine; Female; Fluphenazine; Galactorrhea; Haloperidol; Humans; Hyperprolactinemia; Prolactin; Psychotic Disorders; Thioridazine | 1997 |